These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3490587)

  • 1. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.
    Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M
    JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK; Cross GD; Callaway CS; McDougal JS
    J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis.
    Stoler MH; Eskin TA; Benn S; Angerer RC; Angerer LM
    JAMA; 1986 Nov; 256(17):2360-4. PubMed ID: 3639953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain.
    Sharer LR; Epstein LG; Cho ES; Joshi VV; Meyenhofer MF; Rankin LF; Petito CK
    Hum Pathol; 1986 Mar; 17(3):271-84. PubMed ID: 3005158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of monocyte/macrophages by human T lymphotropic virus type III.
    Ho DD; Rota TR; Hirsch MS
    J Clin Invest; 1986 May; 77(5):1712-5. PubMed ID: 2422213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
    Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
    J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line.
    Getchell JP; Heath JL; Hicks DR; Sporborg C; McGrath CR; Kalyanaraman VS
    J Clin Microbiol; 1986 Apr; 23(4):737-42. PubMed ID: 2422205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.
    Gabuzda DH; Ho DD; de la Monte SM; Hirsch MS; Rota TR; Sobel RA
    Ann Neurol; 1986 Sep; 20(3):289-95. PubMed ID: 3532930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mononuclear phagocytes in HTLV-III/LAV infection.
    Gartner S; Markovits P; Markovitz DM; Kaplan MH; Gallo RC; Popovic M
    Science; 1986 Jul; 233(4760):215-9. PubMed ID: 3014648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS subacute encephalitis. Identification of HIV-infected cells.
    Vazeux R; Brousse N; Jarry A; Henin D; Marche C; Vedrenne C; Mikol J; Wolff M; Michon C; Rozenbaum W
    Am J Pathol; 1987 Mar; 126(3):403-10. PubMed ID: 3548405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.
    Koenig S; Gendelman HE; Orenstein JM; Dal Canto MC; Pezeshkpour GH; Yungbluth M; Janotta F; Aksamit A; Martin MA; Fauci AS
    Science; 1986 Sep; 233(4768):1089-93. PubMed ID: 3016903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
    Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
    J Virol; 1986 Apr; 58(1):116-24. PubMed ID: 3005641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
    Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.